Search

Displaying results 591 - 600 of 7379 in total
  1. Indication

    Mild Dementia due to Parkinson's disease

    go.drugbank.com/conditions/DBCOND0025346
    Drugs: Rivastigmine
    Synonyms: Mild Dementia due to Parkinson's disease
  2. Indication

    Mutations amenable to exon 53 skipping

    go.drugbank.com/conditions/DBCOND0124903
    Drugs: Golodirsen · Viltolarsen
    Synonyms: Mutations amenable to exon 53 skipping
  3. Indication

    Positive response to octreotide or lanreotide

    go.drugbank.com/conditions/DBCOND0130368
    Drugs: Octreotide
    Synonyms: Positive response to octreotide or lanreotide
  4. Indication

    Testicular failure due to bilateral torsion

    go.drugbank.com/conditions/DBCOND0112668
    Drugs: Testosterone cypionate
    Synonyms: Testicular failure due to bilateral torsion
  5. Indication

    Unable to tolerate ursodeoxycholic acid (UDCA)

    go.drugbank.com/conditions/DBCOND0127971
    Drugs: Elafibranor · Obeticholic acid · Seladelpar
    Synonyms: Unable to tolerate ursodeoxycholic acid (UDCA)
  6. Drug

    Mepolizumab

    go.drugbank.com/drugs/DB06612
    ApprovedInvestigational

    This indication was subsequently expanded to cover EGPA on December 12, 2017, and HES on September 25, 2020.[L16518] … Activated eosinophils further stimulate an inflammatory response and also induce tissue lesions and promote fibrosis, all of which contribute to the multifactorial symptomatology of hypereosinophilic diseases

    Products: NUCALA 100 MG SUBKUTAN ENJEKSİYONLUK ÇÖZELTİ İÇİN LİYOFİLİZE TOZ, 1 ADET, NUCALA 100 MG SUBKUTAN ENJEKSİYONLUK ÇÖZELTİ İÇİN LİYOFİLİZE TOZ, 3 ADET
  7. Drug

    Magnesium citrate

    go.drugbank.com/drugs/DB11110
    ApprovedInvestigational

    [T215] Magnesium citrate is considered by the FDA as an approved inactive ingredient for approved drug products under the specifications of oral administration of a maximum concentration of 237 mg.

    Products: MAGGZİUM 400 MG ORAL ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 20 ADET, MAGGZİUM 400 MG ORAL ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 50 ADET
  8. Drug

    Selegiline

    go.drugbank.com/drugs/DB01037
    ApprovedInvestigationalVet approved

    (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeProducts: Nu-selegiline
  9. Drug

    Cetrorelix

    go.drugbank.com/drugs/DB00050
    ApprovedInvestigational

    When undergoing hormone treatment sometimes premature ovulation can occur, leading to eggs that are not ready for fertilization to be released. … Cetrorelix does not allow the premature release of these eggs to occur.

    Products: CETROTIDE 250 MCG ENJEKSİYONLUK ÇÖZELTİ İÇİN TOZ VE ÇÖZÜCÜ, 1 ADET, CETROTIDE 3 MG ENJEKSİYON İÇİN LİYOFİLİZE TOZ İÇEREN FLAKON, 1 ADET
  10. Drug

    Oxaliplatin

    go.drugbank.com/drugs/DB00526
    ApprovedInvestigational

    Compared to cisplatin the two amine groups are replaced by diamino cyclohexane (DACH) group to provide a greater antitumor effect. … [A797] However, this leads to poorer water solubility, which was compensated by the addition of the chloride moieties.

    Synonyms: (SP-4-2-(1R-TRANS))-(1,2-CYCLOHEXANEDIAMINE-N,N')(ETHANEDIOATO(2-)-O,O')PLATINUMProducts: OXIPLEX 50 MG IV INFÜZYON IÇIN LIYOFILIZE TOZ IÇEREN FLAKON, 1 ADET, OXIPLEX 100 MG IV INFÜZYON IÇIN LIYOFILIZE TOZ IÇEREN FLAKON, 1 ADET